Camber Capital Management LP 13D and 13G filings for Myriad Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 08:32 am Sale |
2024-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 3,100,000 3.410% |
-4,535,000 (-59.40%) |
Filing |
| 2024-02-14 08:24 am Purchase |
2023-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 7,635,000 8.500% |
635,000 (+9.07%) |
Filing |
| 2023-02-14 08:46 am Purchase |
2022-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 7,000,000 8.640% |
2,300,000 (+48.94%) |
Filing |
| 2022-05-12 4:06 pm Purchase |
2022-05-02 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 4,700,000 5.850% |
1,950,000 (+70.91%) |
Filing |
| 2022-02-14 09:39 am Sale |
2021-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 2,750,000 3.440% |
-2,250,000 (-45.00%) |
Filing |
| 2021-02-16 08:20 am Purchase |
2020-12-31 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 5,000,000 6.650% |
1,000,000 (+25.00%) |
Filing |
| 2020-06-22 10:01 am Purchase |
2020-06-11 | 13G | Myriad Genetics, Inc. MYGN |
Camber Capital Management LP | 4,000,000 5.370% |
2,500,000 (+166.67%) |
Filing |